Non-Hormonal Options for Hot Flashes: FDA Approves Veozah
Menopause brings a host of uncomfortable physical changes, and severe hot flashes are often the most difficult to manage. For decades, traditional hormone therapy was the primary medical solution. This left women who cannot safely take hormones without highly effective treatments. The FDA approval of Veozah offers a completely new, non-hormonal path to finding real relief.
The Challenge of Treating Hot Flashes
Hot flashes and night sweats are medically known as vasomotor symptoms. Up to 80 percent of women experience these sudden, intense feelings of heat during the menopause transition. For some, the symptoms are mild and pass quickly. For others, they are severe enough to disrupt sleep, daily routines, and overall quality of life.
Historically, doctors prescribed hormone replacement therapy to replace the estrogen the body stops making during menopause. While highly effective, estrogen is not safe for everyone. Women with a history of estrogen-receptor-positive breast cancer, stroke, heart disease, or severe blood clots are typically advised to avoid hormone medications completely. This created a massive gap in care, leaving millions of women to rely on off-label medications or unproven supplements.
What is Veozah?
In May 2023, the U.S. Food and Drug Administration approved a brand new medication called Veozah to treat moderate to severe vasomotor symptoms caused by menopause. Manufactured by Astellas Pharma, Veozah is the brand name for the active drug fezolinetant.
Unlike traditional therapies that add estrogen back into the bloodstream, Veozah works entirely differently. It is an oral pill taken once a day in a 45 mg dose. You take it at the same time each day, with or without food. Because it does not contain estrogen or progesterone, it represents a major breakthrough in menopausal care for women who need safer alternatives.
How Veozah Works in the Brain
To understand why this drug is groundbreaking, it helps to understand how hot flashes actually start.
Your brain has a temperature control center called the hypothalamus. Within the hypothalamus, there are specific nerve cells called KNDy neurons. Before menopause, estrogen keeps these neurons balanced and functioning normally. When your estrogen levels drop during menopause, these KNDy neurons become overactive. They mistakenly signal to your brain that your body is dangerously hot. Your brain reacts by triggering a hot flash to cool you down, causing sudden sweating and flushed skin.
Veozah belongs to a new class of drugs called neurokinin 3 (NK3) receptor antagonists. The medication binds to the NK3 receptors in the brain, essentially blocking the chemical signals that cause the KNDy neurons to misfire. By targeting the exact mechanism that causes the false alarm, Veozah stops the hot flash at the source without using any hormones.
Safety and Potential Side Effects
While Veozah offers an exciting new option, patients and doctors must navigate a few specific health precautions.
The most common side effects reported during clinical trials include:
- Abdominal pain or stomach discomfort
- Diarrhea
- Difficulty sleeping (insomnia)
- Back pain
- Mild hot flashes
The most important safety warning associated with Veozah involves liver health. The medication can cause elevated liver enzymes, which is a sign of liver stress or damage. Because of this risk, your doctor will require a blood test to check your liver function before writing your first prescription. If your liver enzymes are normal and you start taking Veozah, you will still need follow-up blood tests every three months for the first nine months of treatment. Women with existing severe liver damage or kidney disease should not take this medication.
Cost and Insurance Coverage
Because Veozah is a newly approved, first-in-class medication, there is no generic version available yet. The out-of-pocket list price for a 30-day supply is approximately $550.
Insurance coverage is currently expanding as the drug becomes more established. Many commercial health insurance plans now place Veozah on their drug formularies, though they often require a prior authorization from your doctor to confirm you truly need it. To help with the high costs, Astellas Pharma offers a manufacturer savings program. Eligible patients with commercial insurance can pay as little as $30 per month for their prescription. Women on Medicare or Medicaid do not qualify for this specific manufacturer coupon, so Medicare Part D coverage will dictate the exact out-of-pocket price.
Older Non-Hormonal Alternatives
Before Veozah arrived, doctors had very few non-hormonal tools designed specifically for menopause. The only other FDA-approved non-hormonal treatment for hot flashes is Brisdelle. Brisdelle is a 7.5 mg dose of paroxetine, which is a selective serotonin reuptake inhibitor (SSRI) normally used at higher doses to treat depression.
While Brisdelle helps some women, it can cause weight gain, dry mouth, and sexual dysfunction. Most notably, Brisdelle can interfere with tamoxifen, a common medication used to prevent breast cancer recurrence.
Doctors also frequently prescribe other drugs off-label to manage night sweats. These include gabapentin (a nerve pain medication), clonidine (a blood pressure pill), and oxybutynin (used for overactive bladders). While these can take the edge off severe symptoms, none of them target the brain’s KNDy neurons directly like Veozah does.
Frequently Asked Questions
How fast does Veozah start working?
Many women in clinical trials reported a noticeable reduction in the frequency and severity of their hot flashes within the first one to two weeks of taking the daily pill. Full effects are typically seen after a few weeks of consistent use.
Can breast cancer survivors take Veozah?
Yes. Because Veozah is 100 percent non-hormonal, it is generally considered a safe and effective option for breast cancer survivors who suffer from severe hot flashes, pending their doctor’s approval.
Do I need to taper off Veozah if I want to stop?
No, you do not need to gradually reduce your dose. If you and your doctor decide Veozah is no longer necessary, you can stop taking the 45 mg pill. However, your hot flashes will likely return if your body is still in the active stages of menopause.